Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Bone Marrow Neoplasm. Strongest funded area: Translational / Drug Development. Largest gap: Basic Science.
Translational / Drug DevelopmentFunded, Few Publications
3 funded grants in Translational / Drug Development but only 2 related publications found for bone marrow neoplasm. This may indicate early-stage research that hasn't yet produced published results.
Biomarker / DiagnosticsPublished, Not NIH-Funded
8 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for bone marrow neoplasm. Existing research activity suggests this may be a viable area for grant applications.
Clinical ResearchPublished, Not NIH-Funded
9 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for bone marrow neoplasm. Existing research activity suggests this may be a viable area for grant applications.
Basic SciencePublished, Not NIH-Funded
15 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for bone marrow neoplasm. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
8 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for bone marrow neoplasm. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(3 grants)
These grants mention Bone Marrow Neoplasm as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant
